144 related articles for article (PubMed ID: 16515972)
1. Prediction of extravesical disease by preoperative serum markers in patients with clinically organ confined invasive bladder cancer.
Margel D; Tal R; Neuman A; Konichezky M; Sella A; Baniel J
J Urol; 2006 Apr; 175(4):1253-7; discussion 1257. PubMed ID: 16515972
[TBL] [Abstract][Full Text] [Related]
2. Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer.
Margel D; Tal R; Baniel J
J Urol; 2007 Dec; 178(6):2297-300; discussion 2300-1. PubMed ID: 17936837
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
4. Clinical use of serum CA-125 levels in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.
Kouba EJ; Lentz A; Wallen EM; Pruthi RS
Urol Oncol; 2009; 27(5):486-90. PubMed ID: 18555706
[TBL] [Abstract][Full Text] [Related]
5. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
6. External validation of a biomarker based pre-cystectomy algorithm to predict nonorgan confined urothelial cancers.
Margel D; Bostrom P; Baniel J; Yossepowitch O; Zlotta A; Fleshner N
J Urol; 2012 Mar; 187(3):840-4. PubMed ID: 22245328
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
Quek ML; Stein JP; Nichols PW; Cai J; Miranda G; Groshen S; Daneshmand S; Skinner EC; Skinner DG
J Urol; 2005 Jul; 174(1):103-6. PubMed ID: 15947587
[TBL] [Abstract][Full Text] [Related]
8. A novel algorithm to improve pathologic stage prediction of clinically organ-confined muscle-invasive bladder cancer.
Margel D; Harel A; Yossepowitch O; Baniel J
Cancer; 2009 Apr; 115(7):1459-64. PubMed ID: 19152435
[TBL] [Abstract][Full Text] [Related]
9. Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer.
Andrews B; Shariat SF; Kim JH; Wheeler TM; Slawin KM; Lerner SP
J Urol; 2002 Mar; 167(3):1475-81. PubMed ID: 11832773
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy.
Lista F; Andrés G; Cáceres F; Ramón de Fata F; Rodríguez-Barbero JM; Angulo JC
Actas Urol Esp; 2013; 37(7):419-24. PubMed ID: 23773823
[TBL] [Abstract][Full Text] [Related]
11. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
12. The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy.
Guzzo TJ; McNeil BK; Bivalacqua TJ; Elliott DJ; Sokoll LJ; Schoenberg MP
Urol Oncol; 2012; 30(1):44-8. PubMed ID: 20005748
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.
Bruins HM; Huang GJ; Cai J; Skinner DG; Stein JP; Penson DF
J Urol; 2009 Nov; 182(5):2182-7. PubMed ID: 19758623
[TBL] [Abstract][Full Text] [Related]
14. Serum CYFRA 21-1 in patients with invasive bladder cancer and its relevance as a tumor marker during chemotherapy.
Andreadis C; Touloupidis S; Galaktidou G; Kortsaris AH; Boutis A; Mouratidou D
J Urol; 2005 Nov; 174(5):1771-5; discussion 1775-6. PubMed ID: 16217281
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of CA 125 in transitional cell carcinoma of the bladder.
Manvar AM; Wallen EM; Pruthi RS; Nielsen ME
Expert Rev Anticancer Ther; 2010 Dec; 10(12):1877-81. PubMed ID: 21110754
[TBL] [Abstract][Full Text] [Related]
16. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
[TBL] [Abstract][Full Text] [Related]
17. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
[TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma.
Copp HL; Chin JL; Conaway M; Theodorescu D
Cancer; 2006 Jul; 107(1):60-6. PubMed ID: 16691580
[TBL] [Abstract][Full Text] [Related]
20. Computerized tomography for detecting perivesical infiltration and lymph node metastasis in invasive bladder carcinoma.
Baltaci S; Resorlu B; Yagci C; Turkolmez K; Gogus C; Beduk Y
Urol Int; 2008; 81(4):399-402. PubMed ID: 19077399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
